Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleInvestigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
- Where
- Livingston, New Brunswick
- Age
- 18 years and over
- People
- 16
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT05296421 - Phase 1Taking peoplePhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)
- Where
- Orange
- Age
- 18 years and over
- People
- 18
- Run by
- University of California, Irvine
See details and how to joinNCT07549958 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- Where
- Columbia
- Age
- 18 years and over
- People
- 620
- Run by
- University of Missouri-Columbia
See details and how to joinNCT02838836 - No phaseTaking peopleComparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Where
- Birmingham, Duarte, Fresno, Fruitdale, Fullerton, Honolulu, Las Vegas, Los Angeles, Mather, Mobile, Monterey, Palo Alto, Salt Lake City, San Francisco
- Age
- 18 years and over
- People
- 2,996
- Run by
- Stanford University
See details and how to joinNCT05297734 - Phase 1Taking peopleMK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- St Louis
- Age
- 18 years and over
- People
- 51
- Run by
- Washington University School of Medicine
See details and how to joinNCT06648434 - Phase 1Taking peopleA Study of MGC028 in Participants With Advanced Solid Tumors
- Where
- Boston, Grand Rapids, New York, San Antonio, San Francisco, West Valley City
- Age
- 18 years and over
- People
- 124
- Run by
- MacroGenics
See details and how to joinNCT06723236 - No phaseTaking peoplePancreatic Cancer Screening for At-risk Individuals
- Where
- Boston
- Age
- 18 years to 90 years
- People
- 1,395
- Run by
- Beth Israel Deaconess Medical Center
See details and how to joinNCT05006131 - Phase 1/2Taking peopleBasal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 104
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06483555 - Phase 2Taking peopleStereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
- Where
- St Louis
- Age
- 18 years and over
- People
- 36
- Run by
- Washington University School of Medicine
See details and how to joinNCT07126158 - No phaseTaking peopleA Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
- Where
- Norwalk
- Age
- 50 years to 90 years
- People
- 200
- Run by
- Nuvance Health
See details and how to joinNCT03250078 - No phaseTaking peopleA Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
- Where
- New Haven, Norwalk
- Age
- 50 years and over
- People
- 800
- Run by
- Nuvance Health
See details and how to joinNCT03937453 - No phaseTaking peopleThe Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
- Where
- Norwalk
- Age
- 18 years and over
- People
- 200
- Run by
- Nuvance Health
See details and how to joinNCT04406831 - Phase 2Taking peopleA Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
- Where
- Columbus
- Age
- 18 years and over
- People
- 38
- Run by
- Ashish Manne
See details and how to joinNCT05624918 - No phaseTaking peopleCollection of Circulating Biomarkers in Pancreatic Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT05743049 - Phase 1Taking peoplePerioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
- Where
- La Jolla
- Age
- 18 years and over
- People
- 36
- Run by
- University of California, San Diego
See details and how to joinNCT06639724 - Early phase 1Taking peopleFeasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
- Where
- San Francisco
- Age
- 18 years and over
- People
- 10
- Run by
- SONIRE Therapeutics Inc.
See details and how to joinNCT07033689 - No phaseTaking peoplePrehab for Pancreatic Cancer Surgery
- Where
- Worester
- Age
- 18 years and over
- People
- 20
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT07478185 - No phaseTaking peoplePANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
- Where
- New York
- Age
- 18 years to 85 years
- People
- 1,000
- Run by
- Columbia University
See details and how to joinNCT01102556 - Phase 1Taking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - No phaseTaking peopleEvaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
- Where
- Columbus
- Age
- 18 years and over
- People
- 84
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT05961982 - No phaseTaking peopleEvaluation of Resection Techniques for Pancreatic Tumors
- Where
- Dallas
- Age
- 18 years and over
- People
- 431
- Run by
- Methodist Health System
See details and how to joinNCT05128890 - No phaseTaking peopleAccess to Genetic Testing in Underserved Patients With Cancer
- Where
- Los Angeles, Rochester
- Age
- 18 years and over
- People
- 800
- Run by
- University of Southern California
See details and how to joinNCT06422455 - Phase 1/2Taking peoplePanitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
- Where
- Palo Alto
- Age
- 19 years and over
- People
- 27
- Run by
- George Poultsides
See details and how to joinNCT03384238 - Phase 1Taking peopleGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Where
- Duarte, Los Angeles, Stanford
- Age
- 18 years to 75 years
- People
- 18
- Run by
- Anusha Kalbasi
See details and how to joinNCT04119024 - Phase 1/2Not yet taking people in United StatesPDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)
- Where
- Burlington
- Age
- 18 years and over
- People
- 10
- Run by
- University of Vermont
See details and how to joinNCT07477418